Jushi Holdings (JUSHF) Cash & Equivalents (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Cash & Equivalents came in at $39.7 million in Q1 2026, up 52.92% year-on-year from $26.0 million in Q1 2025, and up 65.1% on a QoQ basis from $24.0 million in Q4 2025.
Jushi Holdings (JUSHF) Cash & Equivalents (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cash & Equivalents data on file, last reported at $39.7 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 52.92% year-over-year to $39.7 million in Q1 2026; TTM through Mar 2026 was $39.7 million, a 52.92% increase from a year earlier, with the FY2025 full-year figure at $24.0 million, up 23.19% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $39.7 million, up from $24.0 million in the prior quarter.
- Over the last five years, Cash & Equivalents for JUSHF reached as high as $43.2 million in Q2 2022 and fell as low as $18.5 million in Q1 2023.
- Historically, Cash & Equivalents has averaged $27.0 million across 5 years, with a median of $25.6 million in 2024.
- Across the five-year window, Cash & Equivalents sank 72.41% in 2022 and jumped 52.92% in 2026, its largest moves.
- Year by year, Cash & Equivalents stood at $26.2 million in 2022, then dropped by 0.65% to $26.0 million in 2023, then fell by 25.0% to $19.5 million in 2024, then gained by 23.19% to $24.0 million in 2025, then jumped by 65.1% to $39.7 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $39.7 million in Q1 2026, $24.0 million in Q4 2025, and $23.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.28 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 39.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.70 Mn |
| Dec 31, 2025 | 24.05 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 23.21 Mn |
| Mar 31, 2025 | 25.96 Mn |
| Dec 31, 2024 | 19.52 Mn |
| Sep 30, 2024 | 20.74 Mn |
| Jun 30, 2024 | 32.88 Mn |
| Mar 31, 2024 | 25.29 Mn |
| Dec 31, 2023 | 26.03 Mn |
| Sep 30, 2023 | 25.01 Mn |
| Jun 30, 2023 | 26.78 Mn |
| Mar 31, 2023 | 18.47 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 31.06 Mn |
| Jun 30, 2022 | 43.19 Mn |
| Dec 31, 2021 | 94.96 Mn |